Abstract: A control system of a mobile body is provided with a data acquiring unit and a failure occurrence probability calculation unit. The data acquiring unit acquires data of a plurality of failure factors which may cause a failure on a mounted product mounted on a mobile body. The failure occurrence probability calculation unit calculates, based on data of the plurality of failure factors, a failure occurrence probability of components corresponding to the data of the plurality of failure factors.

Abstract: A vehicle-mounted cooling system includes an air-conditioning refrigerant circuit including a refrigerant passage, a compressor, a heat source-side heat exchanger and a use-side heat exchanger, a battery, and a battery cooling unit cooling the battery using the refrigerant. A control device controls a drive state of the compressor in response to an air-conditioning request and a battery cooling request.

Abstract: An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

Abstract: A control apparatus is applicable to a drive system that measures a user's manipulated parameter, and drives a driving unit constituting a mobility device in accordance with a driving quantity determined based on the user's manipulated parameter. The user's manipulated parameter includes at least one of a user's manipulated variable and a user's manipulated setting. In the control apparatus, a storage unit stores at least one mobility parameter that enables the driving quantity to be determined based on the user's manipulated parameter. A parameter acquiring unit acquires parameter information inputted by a user. The parameter information includes at least one of (i) a user's selected at least one mobility parameter and (ii) information related to the user's selected at least one mobility parameter. In the control apparatus, an updating unit updates, based on the parameter information, the at least one mobility parameter stored in the storage unit.

Abstract: An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

Abstract: An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

Abstract: A control apparatus for a vehicle determines whether to perform either of a first control and a second control. In the first control, power is transferred between a power supply facility outside a vehicle and a power storage apparatus during stopping of the vehicle. In the second control, power is transferred between a rotating electric machine and the power storage apparatus through an inverter during traveling of the vehicle. In response to the first control, the apparatus performs control of the inverter to set a controlled variable to be equal to or less than a first limit value. In response to the second control, the apparatus performs control of the inverter to set a controlled variable to be equal to or less than a second limit value. The apparatus sets at least either of the first and second limit values to a value suppressing decrease in drivability of the vehicle.

Abstract: A cooling control device has an inverter control unit that executes switching control of an inverter for driving a rotary electric machine, and a cooling control unit. On condition that the switching control is stopped, if it is judged that a control temperature is below a threshold value thereof, the cooling control unit executes driving and control of a cooling device such as to lower a degree of cooling of a cooling target component below the degree of cooling when it is judged that the control temperature is above the threshold value. The cooling target component is composed of at least one of the rotary electric machine and the inverter. The control temperature is either a detected temperature value of the cooling target component or an estimated temperature value from a temperature estimation unit that estimates the temperature of the cooling target component.

Abstract: A method of treating a central nervous system disease, the method including administering an agent including a therapeutically effective amount of vitamin B12 to a patient with a central nervous system disease to treat the central nervous system disease. This disclosure also relates to a method of promoting M2 macrophage/microglia induction, inhibiting M1 macrophage/microglia induction, and/or reducing the ratio of M1 macrophage/microglia to M2 macrophage/microglia in a patient in need thereof, the method including administering an agent including a therapeutically effective amount of vitamin B12 to the patient to promote M2 macrophage/microglia induction, inhibit M1 macrophage/microglia induction, and/or reduce the ratio of M1 macrophage/microglia to M2 macrophage/microglia. This disclosure also relates to a pharmaceutical product including vitamin B12.

Abstract: A vehicle-mounted cooling system includes an air-conditioning refrigerant circuit including a refrigerant passage, a compressor, a heat source-side heat exchanger and a use-side heat exchanger, a battery, and a battery cooling unit cooling the battery using the refrigerant. A control device controls a drive state of the compressor in response to an air-conditioning request and a battery cooling request.

Abstract: In an apparatus for controlling a motorized vehicle equipped with a main rechargeable battery, electrical loads electrically connected to the main rechargeable battery via a voltage converter, a converter operating point setter is configured to, when current is passing between the main rechargeable battery and the electrical loads, based on a charging/discharging amount of the main rechargeable battery, set operating points of the voltage converter, each specifying a power conversion efficiency representing a ratio of input power to the electrical loads to output power of the main rechargeable battery and an output current of the voltage converter. A converter controller is configured to, based on the operating point set by the converter operating point setter, cause the voltage converter to convert the voltage of the main rechargeable battery, thereby supplying power to the electrical loads.

Abstract: A method of treating a central nervous system disease, the method including administering an agent including a therapeutically effective amount of vitamin B12 to a patient with a central nervous system disease to treat the central nervous system disease. This disclosure also relates to a method of promoting M2 macrophage/microglia induction, inhibiting M1 macrophage/microglia induction, and/or reducing the ratio of M1 macrophage/microglia to M2 macrophage/microglia in a patient in need thereof, the method including administering an agent including a therapeutically effective amount of vitamin B12 to the patient to promote M2 macrophage/microglia induction, inhibit M1 macrophage/microglia induction, and/or reduce the ratio of M1 macrophage/microglia to M2 macrophage/microglia. This disclosure also relates to a pharmaceutical product including vitamin B12.

Abstract: In an apparatus for controlling a motorized vehicle equipped with a rechargeable battery, a rotary electric machine electrically connected to the rechargeable battery, and electrical loads electrically connected to the rechargeable battery, a machine operating point setter is configured to, when current is passing between the rechargeable battery and the rotary electric machine, set operating points of the rotary electric machine, each specifying a system efficiency representing a ratio of input/output dynamical power of the rotary electric machine to input/output power of the rechargeable battery, a torque of the rotary electric machine, and a rotational speed of the rotary electric machine that are taken as parameters, based on the amount of current flowing through the rechargeable battery. A rotary electric machine controller is configured to control the rotary electric machine to operate at the operating points of the rotary electric machine set by the machine operating point setter.

Abstract: In an apparatus for controlling a motorized vehicle, a rotary electric machine controller is configured to perform intermittent operation by periodically alternating between a driving period and a coasting period. A torque determiner is configured to determine a first torque during the driving period and a second torque during the coasting period. A transition period determiner is configured to determine whether to set a transition period between the driving period and the coasting period. If the transition period is determined to be set, the torque determiner determines a third torque between the first torque and the second torque and within a predetermined rang. The rotary electric machine controller sets the transition period between the driving period and the coasting period and drive the rotary electric machine with the third torque during the transition period.

Abstract: In a starter, current is passed through a solenoid to use the generated electromagnetic force when pushing a pinion gear toward a ring gear, so that the ring gear is engaged with the pinion gear. For this purpose, the starter includes an electromagnetic solenoid, a spring for urging the pinion gear in a direction opposite to that of the electromagnetic solenoid, a connecting member connected to the pinion gear, a stopper for limiting movement of the connecting member to a predetermined position. Being urged by the spring, the pinion gear is disengaged from the ring gear, and the connecting member is retracted to a predetermined position. The starter includes a control circuit that implements control of passing a predetermined current through the solenoid after the disengagement but before retraction of the connecting member to the predetermined position.

Abstract: The present invention relates to a method to suppress the dedifferentiation of cells that readily dedifferentiate, said method including: (1) a step in which the cells are applied to a polymer porous film; and (2) a step in which the cells are cultivated and allowed to multiply, wherein the polymer porous film is a polymer porous film with a three-layer structure, having a surface layer A and a surface layer B that have a plurality of holes, and a macrovoid layer that is sandwiched between the surface layer A and the surface layer B, the average hole diameter of the holes present in the surface layer A is smaller than the average hole diameter of the holes present in the surface layer B, the macrovoid layer has dividing walls that are connected to the surface layers A and B, and a plurality of macrovoids that are surrounded by the dividing walls and the surface layers A and B, and the holes in the surface layers A and B are in communication with the macrovoids.

Abstract: The present invention relates to a method to suppress stem cell differentiation, said method including: (1) a step in which the stem cells are applied to a polymer porous film; and (2) a step in which the stem cells are cultivated and allowed to multiply, wherein the polymer porous film is a polymer porous film with a three-layer structure, having a surface layer A and a surface layer B that have a plurality of holes, and a macrovoid layer that is sandwiched between the surface layer A and the surface layer B, the average hole diameter of the holes present in the surface layer A is smaller than the average hole diameter of the holes present in the surface layer B, the macrovoid layer has dividing walls that are connected to the surface layers A and B, and a plurality of macrovoids that are surrounded by the dividing walls and the surface layers A and B, and the holes in the surface layers A and B are in communication with the macrovoids.

Abstract: In an apparatus for controlling a motorized vehicle equipped with a main rechargeable battery, electrical loads electrically connected to the main rechargeable battery via a voltage converter, a converter operating point setter is configured to, when current is passing between the main rechargeable battery and the electrical loads, based on a charging/discharging amount of the main rechargeable battery, set operating points of the voltage converter, each specifying a power conversion efficiency representing a ratio of input power to the electrical loads to output power of the main rechargeable battery and an output current of the voltage converter. A converter controller is configured to, based on the operating point set by the converter operating point setter, cause the voltage converter to convert the voltage of the main rechargeable battery, thereby supplying power to the electrical loads.

Abstract: In an apparatus for controlling a motorized vehicle, a rotary electric machine controller is configured to perform intermittent operation by periodically alternating between a driving period and a coasting period. A torque determiner is configured to determine a first torque during the driving period and a second torque during the coasting period. A transition period determiner is configured to determine whether to set a transition period between the driving period and the coasting period. If the transition period is determined to be set, the torque determiner determines a third torque between the first torque and the second torque and within a predetermined rang. The rotary electric machine controller sets the transition period between the driving period and the coasting period and drive the rotary electric machine with the third torque during the transition period.

Abstract: In an apparatus for controlling a motorized vehicle equipped with a rechargeable battery, a rotary electric machine electrically connected to the rechargeable battery, and electrical loads electrically connected to the rechargeable battery, a machine operating point setter is configured to, when current is passing between the rechargeable battery and the rotary electric machine, set operating points of the rotary electric machine, each specifying a system efficiency representing a ratio of input/output dynamical power of the rotary electric machine to input/output power of the rechargeable battery, a torque of the rotary electric machine, and a rotational speed of the rotary electric machine that are taken as parameters, based on the amount of current flowing through the rechargeable battery. A rotary electric machine controller is configured to control the rotary electric machine to operate at the operating points of the rotary electric machine set by the machine operating point setter.